Composite Lymphoma
Also known as: Composite Hodgkin and non-Hodgkin lymphoma (disorder) / Composite Hodgkin and non-Hodgkin lymphoma (morphologic abnormality)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB14681 | Cortisone | 1 | Completed | 1 |
| DB00531 | Cyclophosphamide | 1 | Completed | 1 |
| DB00997 | Doxorubicin | 1 | Completed | 1 |
| DB00959 | Methylprednisolone | 1 | Completed | 1 |
| DB09037 | Pembrolizumab | 1 | Completed | 1 |
| DB00635 | Prednisone | 1 | Completed | 1 |
| DB00073 | Rituximab | 1 | Completed | 1 |
| DB14546 | Sulfate ion | 1 | Completed | 1 |
| DB00541 | Vincristine | 1 | Completed | 1 |
| DB17573 | Evorpacept | 1 / 2 | Recruiting | 1 |
| DB00480 | Lenalidomide | 1 / 2 | Recruiting | 1 |
| DB00073 | Rituximab | 1 / 2 | Recruiting | 1 |